On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Issues in GERD
- Definition of GERD
- Los Angeles classification
- Get your definitions right
- NERD is important
- Prevalence of GERD (1)
- Prevalence of GERD (2)
- Symptom relief after 4 weeks in NERD patients
- Predictors of NERD vs. ERD
- NERD is not homogenous
- 24-hr pH study
- Is most NERD MERD?
- Mechanisms of symptom production in NERD
- Sub classification of NERD
- Functional heartburn (1)
- Predictors of functional heartburn vs. pH + NERD
- Development of symptoms in GERD patients
- Laparoscopic fundoplication
- Functional heartburn (2)
- Role of DGER in "resistant" GERD
- NERD: management issues
- What are the limits of GERD?
- Heartburn and quality of life (1)
- Heartburn and quality of life (2)
- GERD in China (1)
- GERD in China (2)
- Symptom severity and quality of life
- Natural history
- Progression in ProGERD (1)
- Progression in ProGERD (2)
- Determination of GERD
- Extra-esophageal, supra-esophageal GERD
- Laryngitis
- Non-acid reflux
- Cough and GERD
- Meta-analysis of primary outcome
- Meta-analysis of cough scores
- Cochrane
- Non-traditional reflux and cough
- Asthma
- PPI and asthma (1)
- PPI and asthma (2)
- Scleroderma and GERD
- The Barrett's dilemma
- How do we proceed?
- Risk factors for Barrett's and adenocarcinoma
- Can we predict progression?
- Genetics
- Screen followed by surveillance?
- Prague criteria
- Barrett's management issues
- GERD management issues
- Summary - approaches to the patients with GERD
- Issues in choosing a PPI
- Key points
Topics Covered
- What is GERD
- NERD non-erosive reflux disease
- Predictors of NERD vs. ERD
- Mechanisms of symptom production in NERD
- Functional heartburn
- Predictors of functional heartburn vs. pH + NERD
- Factors leading to the development of symptoms in GERD patients
- Role of DGER in "resistant" GERD
- NERD: management issues
- The limits of GERD
- Progression in ProGERD
- Extra-esophageal, supra-esophageal GERD
- Laryngitis
- Cough and GERD
- Asthma and GERD
- Scleroderma and GERD
- The Barrett's dilemma
- Risk factors for Barrett's and adenocarcinoma
- Genetic markers that can predict progression
- Barrett's management issues
- GERD management issues
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Quigley, E.M.M. (2011, February 15). The spectrum of GERD implications for assessment and management [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/ABUY2588.Export Citation (RIS)
Publication History
- Published on February 15, 2011
Financial Disclosures
- Prof. Eamonn M. M. Quigley, Consultant: Alimentary Health, Allergen, Commonwealth Laboratories, Rhythm, Salix, Synergy, Vibrant Speaker’s Bureau: Procter and Gamble Grant/Research Support (Principal Investigator): Rhythm, Therevance, Vibrant Stock Shareholder (Self-managed): Alimentary Health